Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer.

Authors:
Peilin Jia
Peilin Jia
Vanderbilt University School of Medicine
Nashville | United States
Yang Liu
Yang Liu
Chinese PLA General Hospital
China
Zhongming Zhao
Zhongming Zhao
Vanderbilt University School of Medicine
United States

BMC Syst Biol 2012 17;6 Suppl 3:S13. Epub 2012 Dec 17.

Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.

Background: Pathway analysis of large-scale omics data assists us with the examination of the cumulative effects of multiple functionally related genes, which are difficult to detect using the traditional single gene/marker analysis. So far, most of the genomic studies have been conducted in a single domain, e.g., by genome-wide association studies (GWAS) or microarray gene expression investigation. A combined analysis of disease susceptibility genes across multiple platforms at the pathway level is an urgent need because it can reveal more reliable and more biologically important information.

Results: We performed an integrative pathway analysis of a GWAS dataset and a microarray gene expression dataset in prostate cancer. We obtained a comprehensive pathway annotation set from knowledge-based public resources, including KEGG pathways and the prostate cancer candidate gene set, and gene sets specifically defined based on cross-platform information. By leveraging on this pathway collection, we first searched for significant pathways in the GWAS dataset using four methods, which represent two broad groups of pathway analysis approaches. The significant pathways identified by each method varied greatly, but the results were more consistent within each method group than between groups. Next, we conducted a gene set enrichment analysis of the microarray gene expression data and found 13 pathways with cross-platform evidence, including "Fc gamma R-mediated phagocytosis" (P GWAS = 0.003, P expr < 0.001, and P combined = 6.18 × 10(-8)), "regulation of actin cytoskeleton" (P GWAS = 0.003, P expr = 0.009, and P combined = 3.34 × 10(-4)), and "Jak-STAT signaling pathway" (P GWAS = 0.001, P expr = 0.084, and P combined = 8.79 × 10(-4)).

Conclusions: Our results provide evidence at both the genetic variation and expression levels that several key pathways might have been involved in the pathological development of prostate cancer. Our framework that employs gene expression data to facilitate pathway analysis of GWAS data is not only feasible but also much needed in studying complex disease.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-0509-6-S3-S13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524313PMC
June 2013
75 Reads

Publication Analysis

Top Keywords

pathway analysis
20
gene expression
20
prostate cancer
16
expression data
12
microarray gene
12
0003 expr
8
gwas 0003
8
gene set
8
gene
8
gwas dataset
8
integrative pathway
8
association studies
8
analysis
8
genome-wide association
8
analysis gwas
8
pathway
7
gwas
7
expression
6
pathways
5
data
5

Similar Publications

Gene, pathway and network frameworks to identify epistatic interactions of single nucleotide polymorphisms derived from GWAS data.

BMC Syst Biol 2012 17;6 Suppl 3:S15. Epub 2012 Dec 17.

Center for Proteomics and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA.

Background: Interactions among genomic loci (also known as epistasis) have been suggested as one of the potential sources of missing heritability in single locus analysis of genome-wide association studies (GWAS). The computational burden of searching for interactions is compounded by the extremely low threshold for identifying significant p-values due to multiple hypothesis testing corrections. Utilizing prior biological knowledge to restrict the set of candidate SNP pairs to be tested can alleviate this problem, but systematic studies that investigate the relative merits of integrating different biological frameworks and GWAS data have not been conducted. Read More

View Article
June 2013

Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.

Hum Reprod 2017 04;32(4):780-793

Endometriosis CaRe Centre, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, UK.

Study Question: Do genome-wide association study (GWAS) data for endometriosis provide insight into novel biological pathways associated with its pathogenesis?

Summary Answer: GWAS analysis uncovered multiple pathways that are statistically enriched for genetic association signals, analysis of Stage A disease highlighted a novel variant in MAP3K4, while top pathways significantly associated with all endometriosis and Stage A disease included several mitogen-activated protein kinase (MAPK)-related pathways.

What Is Known Already: Endometriosis is a complex disease with an estimated heritability of 50%. To date, GWAS revealed 10 genomic regions associated with endometriosis, explaining <4% of heritability, while half of the heritability is estimated to be due to common risk variants. Read More

View Article
April 2017

Detecting discordance enrichment among a series of two-sample genome-wide expression data sets.

BMC Genomics 2017 01 25;18(Suppl 1):1050. Epub 2017 Jan 25.

Department of Medicine, Division of Genomic Medicine, The George Washington University Medical Center, Washington, 20037, D.C., USA.

Background: With the current microarray and RNA-seq technologies, two-sample genome-wide expression data have been widely collected in biological and medical studies. The related differential expression analysis and gene set enrichment analysis have been frequently conducted. Integrative analysis can be conducted when multiple data sets are available. Read More

View Article
January 2017

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.

PLoS One 2011 23;6(11):e26527. Epub 2011 Nov 23.

Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Background: Kallikrein 15 (KLK15)/Prostinogen is a plausible candidate for prostate cancer susceptibility. Elevated KLK15 expression has been reported in prostate cancer and it has been described as an unfavorable prognostic marker for the disease.

Objectives: We performed a comprehensive analysis of association of variants in the KLK15 gene with prostate cancer risk and aggressiveness by genotyping tagSNPs, as well as putative functional SNPs identified by extensive bioinformatics analysis. Read More

View Article
April 2012